SB 1682 allows veterans and first responders aged 21+ with specific conditions (PTSD, major depression, substance use disorder, or end-of-life care needs) to legally use psilocybin for therapeutic purposes under strict conditions. It requires a doctor's certification, a trained facilitator present during use, lab testing of the substance, and limits to 150mg of psilocybin per month. The bill also allocates $2 million for research and shields healthcare providers from liability for following these rules. This is limited to therapeutic use only, not general legalization, and applies only to those enrolled in approved studies.
HB 2817, the Veterans Mental Health Innovation Act, creates a state grant program to fund clinical trials using ibogaine for treating opioid use disorder and other mental health conditions. Eligible entities (like hospitals or research institutions within the state) must partner with a consortium that has submitted an FDA application for ibogaine trials, demonstrate relevant research experience, and match state grant funds with non-state funding. The bill establishes two dedicated state funds: an "Ibogaine Study Fund" for grant awards and an "Intellectual Property Fund" to collect revenue from trial-related patents or treatments, which will support veteran and at-risk population programs. It requires quarterly progress reports from grant recipients and annual legislative updates, with grant applications to begin accepting before November 1, 2026.
HB 2882 creates a state tax credit allowing Missouri taxpayers to reduce their income tax liability by 70% of donations (up to $50,000 annually) to nonprofit organizations providing mental health services to veterans. The credit applies to contributions made to qualified 501(c)(3) organizations meeting specific criteria, including offering comprehensive mental health care through licensed professionals. Taxpayers can carry forward unused credits to the next tax year but cannot claim credits for donations under $100. The program expires after six years unless reauthorized by the legislature.
HB 2673, the "Veterans Well-Being and Resource Outreach Act," would require the Department of Mental Health to create a program encouraging local veterans' organizations to conduct monthly wellness checks for veterans at risk of isolation, homelessness, or mental health crises. The program would use noninvasive outreach to invite at-risk veterans to participate, with check-ins conducted twice monthly by trained veterans or staff who assess medical, housing, mental health, and vocational needs in real time. Organizations participating would not be mandated but would follow state-developed guidelines for implementation. The bill is currently in early legislative stages (prefiled January 2026) and has not yet been enacted.
HB 1717 would allow veterans aged 21+ with PTSD, major depression, substance use disorders, or end-of-life care needs to legally use psilocybin for therapeutic purposes under strict conditions. To qualify, veterans must enroll in a research study, provide physician documentation of their condition, identify a trained facilitator (a licensed mental health professional meeting specific criteria), and have psilocybin tested by a state-licensed lab. The bill prohibits state/local penalties for compliant use, requires a 150mg annual limit, and shields healthcare providers from professional discipline for participating. It also mandates a $2 million state grant for psilocybin research and annual reports on the program’s implementation. This bill is currently pending in committee and has not yet become law.
